Category
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Today's News
More News
Single-dose injectable nanovaccine-in-hydrogel for robust cancer immunotherapy

Single-dose injectable nanovaccine-in-hydrogel for robust cancer immunotherapy

by Thamarasee Jeewandara , Medical XpressIn situ vaccination with single-dose NvIH reduced TME immunosuppression, enhanced TME antitumor immune milieu, and elicited systemic antitumor immunity, result

Single-dose injectable nanovaccine-in-hydrogel for robust cancer immunotherapy

by Thamarasee Jeewandara , Medical XpressIn situ vaccination with single-dose NvIH reduced TME immunosuppression, enhanced TME antitumor immune milieu, and elicited systemic antitumor immunity, result
Drug with a light switch: Researcher investigates chemotherapy without side effects

Drug with a light switch: Researcher investigates chemotherapy without side effects

byLeiden UniversityCredit: Leiden UniversityNausea, neurologic pain and hair loss are some of the severe side effects of chemotherapy. But they are not a necessary hardship, says biochemist Liya

Drug with a light switch: Researcher investigates chemotherapy without side effects

byLeiden UniversityCredit: Leiden UniversityNausea, neurologic pain and hair loss are some of the severe side effects of chemotherapy. But they are not a necessary hardship, says biochemist Liya
Both metabolically healthy and unhealthy forms of obesity found to increase risk of obesity-related cancers

Both metabolically healthy and unhealthy forms of obesity found to increase risk of obesity-related cancers

by European Association for the Study of ObesityCredit: Pixabay/CC0 Public DomainNew research to be presented at this coming week's European Congress on Obesity in Dublin, Ireland (May 17–20) and&

Both metabolically healthy and unhealthy forms of obesity found to increase risk of obesity-related cancers

by European Association for the Study of ObesityCredit: Pixabay/CC0 Public DomainNew research to be presented at this coming week's European Congress on Obesity in Dublin, Ireland (May 17–20) and&
Most cancer screens won't extend lives, but reasons to keep screening remain

Most cancer screens won't extend lives, but reasons to keep screening remain

by Cara MurezWhile new research suggests cancer screenings are not extending lives for the most part, the study's authors stressed that there are still good reasons why people should continue with

Most cancer screens won't extend lives, but reasons to keep screening remain

by Cara MurezWhile new research suggests cancer screenings are not extending lives for the most part, the study's authors stressed that there are still good reasons why people should continue with
Surviving lung cancer is just the beginning

Surviving lung cancer is just the beginning

by Catherine Granger and Selina Parry,University of MelbourneCredit: Unsplash/CC0 Public DomainMore than 14,000 cases of lung cancerwere diagnosed in Australiain 2022. Survival rates

Surviving lung cancer is just the beginning

by Catherine Granger and Selina Parry,University of MelbourneCredit: Unsplash/CC0 Public DomainMore than 14,000 cases of lung cancerwere diagnosed in Australiain 2022. Survival rates
From tragedy, a new potential cancer treatment

From tragedy, a new potential cancer treatment

byCold Spring Harbor LaboratoryCold Spring Harbor Laboratory Professor Adrian Krainer developed several antisense oligonucleotide (ASO) molecules for a new potential cancer treatment, but the mo

From tragedy, a new potential cancer treatment

byCold Spring Harbor LaboratoryCold Spring Harbor Laboratory Professor Adrian Krainer developed several antisense oligonucleotide (ASO) molecules for a new potential cancer treatment, but the mo
Overall incidence rate of pediatric cancer increased from 2003 to 2019

Overall incidence rate of pediatric cancer increased from 2003 to 2019

by Elana GotkineThe overall incidence rate of pediatric cancer increased on average from 2003 to 2019, peaking in 2016, according to a study published online July 11 in theJournal of the Nationa

Overall incidence rate of pediatric cancer increased from 2003 to 2019

by Elana GotkineThe overall incidence rate of pediatric cancer increased on average from 2003 to 2019, peaking in 2016, according to a study published online July 11 in theJournal of the Nationa
Estrogen and PARP inhibitor combination for advanced ER+ breast cancer shows promise in preclinical models

Estrogen and PARP inhibitor combination for advanced ER+ breast cancer shows promise in preclinical models

byDartmouth HealthCredit: Unsplash/CC0 Public DomainAdvanced estrogen receptor-positive (ER+) breast cancer can be especially difficult to treat. A new study by researchers at Dartmouth Cancer C

Estrogen and PARP inhibitor combination for advanced ER+ breast cancer shows promise in preclinical models

byDartmouth HealthCredit: Unsplash/CC0 Public DomainAdvanced estrogen receptor-positive (ER+) breast cancer can be especially difficult to treat. A new study by researchers at Dartmouth Cancer C
ERβ as a mediator of estrogen signaling in inflammatory breast cancer

ERβ as a mediator of estrogen signaling in inflammatory breast cancer

by Impact Journals LLCFigure 1: Upon activation by the specific agonist LY500307 ERβ binds to estrogen receptor binding elements (ERE) inregulatory regions of GPR141 and ELMO1 genes and suppresses the

ERβ as a mediator of estrogen signaling in inflammatory breast cancer

by Impact Journals LLCFigure 1: Upon activation by the specific agonist LY500307 ERβ binds to estrogen receptor binding elements (ERE) inregulatory regions of GPR141 and ELMO1 genes and suppresses the
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...